In a 24-week trial, semaglutide led to a 52% reduction in albuminuria and improved kidney health in individuals with chronic kidney disease and obesity.
Ozempic effective for patients with chronic kidney damage
- Post author:
- Post published:October 28, 2024
- Post category:uncategorized